Morinda citrifolia Linn. (noni) and its potential in obesity-related metabolic dysfunction

Nutrients

Volumn 9, Issue 6, 2017, Pages

  Inada, Aline Carla ^a   Figueiredo, Priscila Silva ^a   dos Santos Eichler, Rosângela Aparecida ^b   Freitas, Karine de Cássia ^a   Hiane, Priscila Aiko ^a   de Castro, Alinne Pereira ^c   Guimarães, Rita de Cássia Avellaneda ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDADE CATÓLICA DOM BOSCO   (Brazil)

Author keywords

Health; Morinda citrifolia L; Obesity; Obesity related metabolic dysfunction

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CATECHIN; CHLOROGENIC ACID; COUMARIN; EPICATECHIN; GLUTATHIONE; IRIDOID; LIGNAN; MORINDA CITRIFOLIA EXTRACT; PHENOL; QUINONE DERIVATIVE; SUPEROXIDE DISMUTASE; TRITERPENOID;

ANTIBACTERIAL ACTIVITY; BIOMASS PRODUCTION; CHEMICAL COMPOSITION; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTESTINE FLORA; LIPID METABOLISM; METABOLIC DISORDER; MORINDA CITRIFOLIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL VALUE; OBESITY; PHASE 1 CLINICAL TRIAL (TOPIC); PHYTOCHEMISTRY; PHYTOTOXICITY; PLANT STRUCTURES; REVIEW; SIGNAL TRANSDUCTION; CHEMISTRY; COMPLICATION; METABOLIC SYNDROME X; MORINDA; PHYTOTHERAPY;

HUMANS; METABOLIC SYNDROME; MORINDA; OBESITY; PHYTOTHERAPY;

EID: 85019731715     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9060540     Document Type: Review

References (168)

1. World Health Organization. Obesity and Overweight. Available online: http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed on 12 November 2016).
2. Flegal, K.M.; Carroll, M.D.; Ogden, C.L.; Johnson, C.L. Prevalence and trends in obesity among U.S. adults, 1999–2000. JAMA 2002, 303, 235–241. [CrossRef] [PubMed]
3. Olshanky, S.J.; Passaro, D.J.; Hershow, R.C.; Layden, J.; Carnes, B.A.; Brody, J.; Hayflick, L.; Butler, R.N.; Allison, D.B.; Ludwig, D.S. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 2005, 352, 1138–1145. [CrossRef] [PubMed]
4. World Health Organization Regional Office for Europe. Available online: http://www.euro.who.int/__data/assets/pdf_file/0003/294474/European-Food-Nutrition-Action-Plan-20152020-en.pdf (accessed on 12 November 2016).
5. World Health Organization. Obesity and Diabetes: The Slow-Motion Disaster Keynote Address at the 47th Meeting of the National Academy of Medicine. Available online: http://www.who.int/dg/speeches/2016/obesity-diabetes-disaster/en/ (accessed on 12 November 2016).
6. ABESO—Associação Brasileira Para o Estudo da Obesidade e da Síndrome Metabólica. Mapa da Obesidade. Available online: http://www.abeso.org.br/atitude-saudavel/mapaobesidad (accessed on 12 November 2016).
7. Patel, J.J.; Rosenthal, M.D.; Miller, K.R.; Codner, P.; Kiraly, L.; Martindale, R.G. The critical care obesity paradox and implications for nutrition support. Curr. Gastroenterol. Rep. 2016, 18, 45. [CrossRef] [PubMed]
8. Reddon, H.; Gueant, J.L.; Meyre, D. The importance of gene-environment interactions in human obesity. Clin. Sci. 2016, 130, 1571–1597. [CrossRef] [PubMed]
9. Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R.; Gordon, J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027–1031. [CrossRef] [PubMed]
10. Van Gaal, L.F.; Mertens, I.L.; De Block, C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444, 875–880. [CrossRef] [PubMed]
11. Gross, B.; Pawlak, M.; Lefebvre, P.; Staels, B. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat. Rev. Endocrinol. 2017, 13, 36–49. [CrossRef] [PubMed]
12. Mohamed, S. Functional foods against metabolic syndrome (obesity, diabetes, hypertension and dyslipidemia) and cardiovasular disease. Trends Food Sci. Technol. 2014, 35, 114–128. [CrossRef]
13. Sun, N.N.; Wu, T.Y.; Chau, C.F. Natural dietary and herbal products in anti-obesity treatment. Molecules 2016, 21, 77–91. [CrossRef] [PubMed]
14. Singh, D.R. Morinda citrifolia L. (Noni): A review of the scientifica validation for its nutritional and therapeutical properties. J. Diabetes Endocrinol. 2012, 3, 77–91. [CrossRef]
15. Health Canada. Policy Paper—Nutraceuticals/Functional Foods and Health Claims on Foods. Available online: http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/nutra-funct_foods-nutrafonct_alimenteng.php (accessed on 15 November 2016).
16. Arulselvan, P.; Fard, M.T.; Tan, W.S.; Gothai, S.; Fakurazi, S.; Norhaizan, M.E.; Kumar, S.S. Role of antioxidants and natural products in inflammation. Oxid. Med. Cell. Longev. 2016, 2016. [CrossRef] [PubMed]
17. Zhang, W.M.; Wang, W.; Zhang, J.J.; Wang, Z.R.; Wang, Y.; Hao, W.J.; Huang, W.Y. Antibacterial constituents of Hainan Morinda citrifolia (noni) leaves. J. Food Sci. 2016, 81, M1192–M1196. [CrossRef] [PubMed]
18. Abou Assi, R.; Darwis, Y.; Abdulbaqi, I.M.; Khan, A.A.; Vuanghao, L.; Laghari, M.H. Morinda citrifolia (noni): A comprehensive review on its industrial uses, pharmacological activities, and clinical trials. Arab. J. Chem. 2015. [CrossRef]
19. Mahattanadul, S.; Ridtitid, W.; Nima, S.; Phdoongsombut, N.; Ratanasuwon, P.; Kasiwong, S. Effects of Morinda citrifolia aqueous fruit extract and its biomarker scopoletin on reflux esophagitis and gastric ulcer in rats. J. Ethnopharmacol. 2011, 134, 243–250. [CrossRef] [PubMed]
20. Hiramatsu, T.; Imoto, M.; Koyano, T.; Umezawa, K. Induction of nornal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. Cancer Lett. 1993, 73, 161–166. [CrossRef]
21. Anekpankul, T.; Goto, M.; Sasaki, M.; Pavasant, P.; Shotipruk, A. Extraction of anti-cancer damnacanthal from roots of Morinda citrifolia by subcritical water. Sep. Purif. Technol. 2007, 55, 343–349. [CrossRef]
22. Sattar, F.A.; Ahmed, F.; Ahmed, N.; Sattar, S.A.; Malghani, M.A.; Choudhary, M.I. A double-blind, randomized, clinical trial on the antileishmanial activity of a Morinda citrifolia (noni) stem extract and its major constituents. Nat. Prod. Commun. 2012, 7, 195–196. [PubMed]
23. Siddiqui, B.S.; Sattar, F.A.; Begum, S.; Dar, A.; Nadeem, M.; Gilani, A.H.; Mandukhail, S.R.; Ahmad, A.; Tauseef, S. A note on anti-leishmanial, spasmolytic and spasmogenic, antioxidant and antimicrobial activities of fruits, leaves and stem of Morinda citrifolia Linn—An important medicinal and food supplement plant. Med. Aromat. Plants 2014, 3, 1–3. [CrossRef]
24. Palu, A.K.; Seifulla, R.D.; West, B.J. Morinda citrifolia L. (noni) improves athlete endurance: Its mechanisms of action. J. Med. Plant. Res. 2008, 2, 154–158.
25. Wang, M.Y.; Peng, L.; Weidenbacher-Hoper, V.; Deng, S.; Anderson, G.; West, B. Noni juice improves serum lipid profiles and other risk markers in cigarette smokers. Sci. World J. 2012, 2012, 1–8. [CrossRef] [PubMed]
26. Issell, B.F.; Gotay, C.C.; Pagano, I.; Franke, A.A. Using quality of life measures in a phase I clinical trial of noni in patients with advanced cancer to select a phase II dose. J. Diet. Suppl. 2009, 6, 1–11. [CrossRef] [PubMed]
27. Tilg, H.; Moschen, A.R.; Roden, M. NAFLD and diabetes mellitus. Nat. Rev. Gastroenterol. Hepatol. 2016. [CrossRef] [PubMed]
28. Wang, F.; Han, L.; Hu, D. Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis. Clin. Chim. Acta 2016, 464, 57–63. [CrossRef] [PubMed]
29. Chan-Blanco, Y.; Vaillant, F.; Mercedes Perez, A.; Reynes, M.; Brillouet, J.-M.; Brat, P. The noni fruit (Morinda citrifolia L.): A review of agricultural research, nutritional and therapeutic properties. J. Food Comp. Anal. 2006, 19, 645–654. [CrossRef]
30. Pawlus, A.D.; Kinghorn, A.D. Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J. Pharm. Pharmacol. 2007, 59, 1587–1609. [CrossRef] [PubMed]
31. Wang, M.; Kikuzaki, H.; Jin, Y.; Nakatani, N.; Zhu, N.; Csiszar, K.; Boyd, C.; Rosen, R.T.; Ghai, G.; Ho, C.T. Novel glycosides from noni (Morinda citrifolia). J. Nat. Prod. 2000, 63. [CrossRef]
32. Heinicke, R.M. The pharmacologically active ingredient of noni. Pac. Trop. Bot. Gard. Bull. 1985, 15, 10–14.
33. Dixon, A.R.; McMillan, H.; Etkin, N.L. Ferment this: The transformation of noni traditional Polynesian medicine (Morinda citrifolia, Rubiaceae). Econ. Bot. 1999, 53, 51–68. [CrossRef]
34. Nerurkar, P.V.; Hwang, P.W.; Saksa, E. Anti-diabetic potential of noni: The yin and the yang. Molecules 2015, 20, 17684–17719. [CrossRef] [PubMed]
35. Samoylenko, V.; Zhao, J.; Dunbar, D.C.; Khan, I.A.; Rushing, J.W.; Muhammad, I. New constituents from noni (Morinda citrifolia) fruit juice. J. Agric. Food Chem. 2006, 54, 6398–6402. [CrossRef] [PubMed]
36. Motshakeri, M.; Ghazali, H.M. Nutritional, phytochemical and commercial quality of noni fruit: A multi-beneficial gift from nature. Trends Food Sci. Technol. 2015, 45, 118–129. [CrossRef]
37. Nelson, S.C. Noni cultivation in Hawaii. Fruit Nuts 2001, 4, 1–4.
38. Chunhieng, M.T. Development of New Food Health Tropical: Application at the Nuts bre’ sil Bertholettia Excelsa and the Fruit of Morinda citrifolia Cambodia. Ph.D Thesis, I'Institut National Polytechnique de Lorraine (INPL), Nancy, France, 2003.
39. Peerzada, N.; Renaud, S.; Ryan, P. Vitamin C and elemental composition of some bushfruits. J. Plant Nutr. 1990, 13, 787–793. [CrossRef]
40. Aalbersberg, W.G.L.; Hussein, S.; Sotheeswaran, S.; Parkinson, S. Carotenoids in the leaves of Morinda citrifolia. J. Herbs Spices Med. Plants 2014, 2, 51–54. [CrossRef]
41. Millonig, G.; Stadlmann, S.; Vogel, W. Herbal hepatoxicity: Acute hepatitis caused by a noni preparation (Morinda citrifolia). Eur. J. Gastroenterol. Hepatol. 2005, 17, 445–447. [CrossRef] [PubMed]
42. Yang, J.; Gadi, R.; Thomson, T. Antioxidant capacity, total phenols, and ascorbic acid content of noni (Morinda citrifolia) fruits and leaves at various stages of maturity. Micronesica 2011, 41, 167–176.
43. Lin, Y.L.; Chang, Y.Y.; Yang, D.J.; Tzang, B.S.; Chen, Y.C. Beneficial effects of noni (Morinda citrifolia L.) juice on livers of high-fat dietary hamsters. Food Chem. 2013, 140, 31–38. [CrossRef] [PubMed]
44. Badimon, L.; Vilahur, G.; Padro, T. Nutraceuticals and atherosclerosis: Human trials. Cardiovasc. Ther. 2010, 28, 202–215. [CrossRef] [PubMed]
45. Hsu, C.L.; Yen, G.C. Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J. Agric. Food Chem. 2007, 55, 8404–8410. [CrossRef] [PubMed]
46. Li, S.Y.; Chang, C.Q.; Ma, F.Y.; Yu, C.L. Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-α in golden hamsters fed on high fat diet. Biomed. Environ. Sci. 2009, 22, 122–129. [CrossRef]
47. Ong, K.W.; Hsu, A.; Tan, B.K. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by AMPK activation. Biochem. Pharmacol. 2013, 85, 1341–1351. [CrossRef] [PubMed]
48. Lin, Y.L.; Chou, C.H.; Yang, D.J.; Chen, J.W.; Tzang, B.S.; Chen, Y.C. Hypolipidemic and antioxidative effects of noni (Morinda citrifolia L.) juice on high- fat/cholesterol-dietary hamsters. Plant Foods Hum. Nutr. 2012, 67, 294–302. [CrossRef] [PubMed]
49. Nerurkar, P.V.; Nishioka, A.; Eck, P.O.; Johns, L.M.; Volper, E.; Nerurkar, V.R. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FOXO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice. Br. J. Nutr. 2012, 108, 218–228. [CrossRef] [PubMed]
50. Pak-Dek, M.S.; Abdul-Hamid, A.; Osman, A.; Soh, C.S. Inhibitory effect of Morinda citrifolia L. on lipoprotein lipase activity. J. Food Sci. 2008, 73, C595–C598. [CrossRef] [PubMed]
51. Sahib, N.G.; Hamid, A.A.; Kitts, D.; Purnama, M.; Saari, N.; Abas, F. The effects of Morinda citrifolia, Momordica charantia and Centella asiatica extracts on lipoprotein lipase and 3T3-L1 preadipocytes. J. Food Biochem. 2011, 35, 1186–1205. [CrossRef]
52. Sang, S.; Cheng, X.; Zhu, N.; Stark, R.E.; Badmaev, V.; Ghai, G.; Rosen, R.T.; Ho, C.-T. Flavonol glycosides and novel iridoid glycoside from the leaves of Morinda citrifolia. J. Agric. Food Chem. 2001, 49, 4478–4481. [CrossRef] [PubMed]
53. Fang, X.K.; Gao, J.; Zhu, D.N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci. 2008, 82, 615–622. [CrossRef] [PubMed]
54. Kampkotter, A.; Nkwonkam, C.G.; Zurawski, R.F.; Timpel, C.; Chovolou, Y.; Watjen, W.; Kahl, R. Investigations of protective effects of the flavonoids quercetin and rutin on stress resistance in the model organism Caenorhabditis elegans. Toxicology 2007, 234, 113–123. [CrossRef] [PubMed]
55. Wigati, D.; Anwar, K.; Sudarsono D; Nugroho, A.E. Hypotensive activity of ethanolic extracts of Morinda citrifolia L. leaves and fruit in dexamethasone-induced hypertensive rat. J. Evid. Based Complement. Altern. Med. 2017, 22, 107–113. [CrossRef] [PubMed]
56. Korkmaz, A.; Kolankaya, D. Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J. Surg. Res. 2010, 164, 309–315. [CrossRef] [PubMed]
57. Kamiya, K.; Tanaka, Y.; Endang, H.; Umar, M.; Satake, T. New anthraquinone and iridoid from the fruits of Morinda citrifolia. Chem. Pharm. Bull. 2005, 53, 1597–1599. [CrossRef] [PubMed]
58. Lin, C.F.; Ni, C.L.; Huang, Y.L.; Sheu, S.J.; Chen, C.C. Lignans and anthraquinones from the fruits of Morinda citrifolia. Nat. Prod. Res. 2007, 21, 1199–1204. [CrossRef] [PubMed]
59. Su, B.N.; Pawlus, A.D.; Jung, H.A.; Keller, W.J.; McLaughlin, J.L.; Kinghorn, A.D. Chemical constituents of Morinda citrifolia (noni) and their antioxidant activity. J. Nat. Prod. 2005, 68, 592–595. [CrossRef] [PubMed]
60. Kamiya, K.; Tanaka, Y.; Endang, H.; Umar, M.; Satake, T. Chemical constituents of Morinda citrifolia fruits inhibit cooper-induced-low-density lipoprotein oxidation. J. Agric. Food Chem. 2004, 52, 5843–5848. [CrossRef] [PubMed]
61. Nguyen, P.H.; Yang, J.L.; Uddin, M.N.; Park, S.L.; Lim, S.I.; Jung, D.W.; Williams, D.R.; Oh, W.K. Protein Tyrosine Phosphatase 1b (PTP1b) inhibitors from Morinda citrifolia (noni) and their insulin mimetic activity. J. Nat. Prod. 2013, 76, 2080–2087. [CrossRef] [PubMed]
62. Zhang, W.Y.; Lee, J.J.; Kim, Y.; Kim, I.S.; Park, J.S.; Myung, C.S. Amelioration of insulin resistance by scopoletin in high-glucose-induced, insulin-resistant Hepg2 cells. Horm. Metab. Res. 2010, 42, 930–935. [CrossRef] [PubMed]
63. Shenoy, J.P.; Pai, P.G.; Shoeb, A.; Gokul, P.; Kulkarni, A.; Kotian, M.S. An evaluation of diuretic activity of Morinda citrifolia (Linn) (noni) fruit juice in normal rats. Int. J. Pharm. Pharm. Sci. 2011, 3, 119–121.
64. Awang, D.V.C. Tyler’s Herbs of Choice: The Therapeutic Use of Phytomedicinals, 3rd ed.; Taylor & Francis Group: Boca Raton, FL, USA, 2009.
65. Hook, I.; McGee, A.; Henman, M. Evaluation of dandelion for diuretic activity and variation in potassium content. Pharm. Biol. 1993, 31, 29–34. [CrossRef]
66. Sang, S.; Wang, M.; He, K.; Liu, G.; Dong, Z.; Badmaev, V.; Zheng, Q.Y.; Ghai, G.; Rosen, R.T.; Ho, C.-T. Chemical components in noni fruits and leaves (Morinda citrifolia L.). ACS Symp. Ser. 2001, 803, 134–150.
67. Jayaprakasam, B.; Olson, L.K.; Schutzki, R.E.; Tai, M.H.; Nair, M.G. Amelioration of obesity and glucose intolerance in high-fat-fed C57Bl/6 mice by anthocyanins and ursolic acid in cornelian cherry (Cornus mas). J. Agric. Food Chem. 2006, 54, 243–248. [CrossRef] [PubMed]
68. Kunkel, S.D.; Elmore, C.J.; Bongers, K.S.; Ebert, S.M.; Fox, D.K.; Dyle, M.C.; Bullard, S.A.; Adams, C.M. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS ONE 2012, 7, e39332. [CrossRef] [PubMed]
69. Norberg, A.; Hoa, N.K.; Liepinsh, E.; Van Phan, D.; Thuan, N.D.; Jornvall, H.; Sillard, R.; Ostenson, C.G. A novel insulin-releasing substance, phanoside, from the plant Gynostemma pentaphyllum. J. Biol. Chem. 2004, 279, 41361–41367. [CrossRef] [PubMed]
70. Senthil, N.; Balu, P.M.; Murugesan, K. Antihyperglycemic effect of spirulina, insulin and Morinda citrifolia against streptozotocin induced diabetic rats. Int. J. Curr. Microbiol. Appl. Sci. 2013, 2, 537–559.
71. Mahadeva Rao, U.S.; Subramanian, S. Biochemical evaluation of antihyperglycemic and antioxidative effects of Morinda citrifolia fruit extract studied in streptozotocin-induced diabetic rats. Med. Chem. Res. 2008, 18, 433–446. [CrossRef]
72. Liu, Q.; Kim, S.B.; Ahn, J.H.; Hwang, B.Y.; Kim, S.Y.; Lee, M.K. Anthraquinones from Morinda officinalis roots enhance adipocyte differentiation in 3T3-L1 cells. Nat. Prod. Res. 2012, 26, 1750–1754. [CrossRef] [PubMed]
73. Kamiya, K.; Hamabe, W.; Harada, S.; Murakami, R.; Tokuyama, S.; Satake, T. Chemical constituents of Morinda citrifolia roots exhibit hypoglycemic effects in streptozotocin-induced diabetic mice. Biol. Pharm. Bull. 2008, 31, 935–938. [CrossRef] [PubMed]
74. Malik, E.M.; Muller, C.E. Anthraquinones as pharmacological tools and drugs. Med. Res. Rev. 2016, 36, 705–748. [CrossRef] [PubMed]
75. Teponno, R.B.; Kusari, S.; Spiteller, M. Recent advances in research on lignans and neolignans. Nat. Prod. Rep. 2016, 33, 1044–1092. [CrossRef] [PubMed]
76. Lee, S.Y.; Park, S.L.; Hwang, J.T.; Yi, S.H.; Nam, Y.D.; Lim, S.I. Anti-diabetic effect of Morinda citrifolia (noni) fermented by Cheonggukjang in kk-a(y) diabetic mice. Evid. Based Complement. Alternat. Med. 2012, 2012. [CrossRef] [PubMed]
77. Cargnin, S.T.; Gnoatto, S.B. Ursolic acid from apple pomace and traditional plants: A valuable triterpenoid with functional properties. Food Chem. 2017, 220, 477–489. [CrossRef] [PubMed]
78. Wozniak, L.; Skapska, S.; Marszalek, K. Ursolic acid—a pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules 2015, 20, 20614–20641. [CrossRef] [PubMed]
79. Barreto, R.S.; Albuquerque-Junior, R.L.; Araujo, A.A.; Almeida, J.R.; Santos, M.R.; Barreto, A.S.; DeSantana, J.M.; Siqueira-Lima, P.S.; Quintans, J.S.; Quintans-Junior, L.J. A systematic review of the wound-healing effects of monoterpenes and iridoid derivatives. Molecules 2014, 19, 846–862. [CrossRef] [PubMed]
80. Murata, K.; Abe, Y.; Futamura-Masuda, M.; Uwaya, A.; Isami, F.; Deng, S.; Matsuda, H. Effect of Morinda citrifolia fruit extract and its iridoid glycosides on blood fluidity. J. Nat. Med. 2014, 68, 498–504. [CrossRef] [PubMed]
81. Sang, S.; Cheng, X.; Zhu, N.; Wang, M.; Jhoo, J.-W.; Stark, R.E.; Badmaev, V.; Ghai, G.; Rosen, R.T.; Ho, C.-T. Iridoid glycosides from the leaves of Morinda citrifolia. J. Nat. Prod. 2001, 64, 799–800. [CrossRef] [PubMed]
82. Stadlbauer, V.; Fickert, P.; Lackner, C.; Schmerlaib, J.; Krisper, P.; Trauner, M.; Stauber, R.E. Hepatoxicity of noni juice: Report of two cases. World J. Gastroenterol. 2005, 15, 4758–4760. [CrossRef]
83. Shalan, N.A.A.M.; Mustapha, N.M.; Mohamed, S. Chronic toxicity evaluation of Morinda citrifolia fruit and leaf in mice. Regul. Toxicol. Pharmacol. 2016, 83, 46–53. [CrossRef] [PubMed]
84. Inoue, K.; Yoshida, M.; Takahashi, M.; Fujimoto, H.; Shibutani, M.; Hirose, M.; Nishikawa, A. Carcinogenic potential of alizarin and rubiadin, components of madder color, in a rat medium-term multi-organ bioassay. Cancer Sci. 2009, 100, 2261–2267. [CrossRef] [PubMed]
85. West, B.J.; Jensen, C.J.; Westendorf, J. Noni juice is not hepatotoxic. World J. Gastroenterol. 2006, 12, 3616–3619. [CrossRef] [PubMed]
86. Westendorf, J.; Effenberger, K.; Iznaguen, H.; Basar, S. Toxicological and analytical investigations of noni (Morinda citrifolia) fruit juice. J. Agric. Food Chem. 2007, 55, 529–537. [CrossRef] [PubMed]
87. West, B.J.; Su, C.X.; Jensen, C.J. Hepatoxicity and subchronic tests of Morinda citrifolia (noni) fruit. J. Toxicol. Sci. 2009, 34, 581–585. [PubMed]
88. Ahmad, A.N.; Mat Daud, Z.A.; Ismail, A. Review on potential therapeutic effect of Morinda citrifolia L. Curr. Opin. Food Sci. 2016, 8, 62–67. [CrossRef]
89. Mohd Zin, Z.; Abdul Hamid, A.; Osman, A.; Saari, N.; Misran, A. Isolation and identification of antioxidative compound from fruit of mengkudu (Morinda citrifolia L.). Int. J. Food Prop. 2007, 10, 363–373. [CrossRef]
90. Elo, H.; Kuure, M.; Pelttari, E. Correlation of the antimicrobial activity of salicylaldehydes with broadening of the NMR signal of the hydroxyl proton. Possible involvement of proton exchange processes in the antimicrobial activity. Eur. J. Med. Chem. 2015, 92, 750–753. [CrossRef] [PubMed]
91. Palu, A.K.; Kim, A.H.; West, B.J.; Deng, S.; Jensen, J.; White, L. The effects of Morinda citrifolia L. (noni) on the immune system: Its molecular mechanisms of action. J. Ethnopharmacol. 2007, 115, 502–506. [CrossRef] [PubMed]
92. Shalan, N.A.A.M.; Mustapha, N.M.; Mohamed, S. Morinda citrifolia leaf enhanced performance by improving angiogenesis, mitochondrial biogenesis, antioxidant, anti-inflammatory & stress responses. Food Chem. 2016, 212, 443–452.
93. Gilani, A.H.; Mandukhail, S.U.; Iqbal, J.; Yasinzai, M.; Aziz, N.; Khan, A.; Najeebur, R. Antispasmodic and vasodilator activities of Morinda citrifolia root extract are mediated through blockade of voltage dependent calcium channels. BMC Complement. Altern. Med. 2010, 10. [CrossRef] [PubMed]
94. Rosen, E.D.; Spiegelman, B.M. What we talk about when we talk about fat. Cell 2014, 156, 20–44. [CrossRef] [PubMed]
95. Wu, J.; Bostrom, P.; Sparks, L.M.; Ye, L.; Choi, J.H.; Giang, A.H.; Khandekar, M.; Virtanen, K.A.; Nuutila, P.; Schaart, G.; et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150, 366–376. [CrossRef] [PubMed]
96. Ouchi, N.; Parker, J.L.; Lugus, J.J.; Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85–97. [CrossRef] [PubMed]
97. Proenca, A.R.; Sertie, R.A.; Oliveira, A.C.; Campaaa, A.B.; Caminhotto, R.O.; Chimin, P.; Lima, F.B. New concepts in white adipose tissue physiology. Braz. J. Med. Biol. Res. 2014. [CrossRef] [PubMed]
98. Vazquez-Vela, M.E.; Torres, N.; Tovar, A.R. White adipose tissue as endocrine organ and its role in obesity. Arch. Med. Res. 2008, 39, 715–728. [CrossRef] [PubMed]
99. Smith, U.; Kahn, B.B. Adipose tissue regulates insulin sensitivity: Role of adipogenesis, de novo lipogenesis and novel lipids. J. Intern. Med. 2016, 280, 465–475. [CrossRef] [PubMed]
100. Cook, K.S.; Min, H.Y.; Johnson, D.; Chaplinsky, R.J.; Flier, J.S.; Hunt, C.R.; Spiegelman, B.M. Adipsin: A circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 1987, 237, 402–405. [CrossRef] [PubMed]
101. Hotamisligil, G.S.; Shargill, N.S.; Spiegelman, B.M. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 1994, 259, 87–91. [CrossRef]
102. Zhang, Y.Y.; Proenca, R.; Maffei, M.; Barone, M.; Leopold, L.; Friedman, J.M. Positional cloning of the mouse obese gene and its human homolog. Nature 1994, 372, 425–432. [CrossRef] [PubMed]
103. Hu, E.; Liang, P.; Spiegelman, B.M. Adipoq is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 1996, 271, 10697–10703. [PubMed]
104. Lago, F.; Dieguez, C.; Gomez-Reino, J.; Gualillo, O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 2007, 18, 313–325. [CrossRef] [PubMed]
105. Makki, K.; Froguel, P.; Wolowczuk, I. Adipose tissue in obesity-related inflammation and insulin resistance: Cells, cytokines, and chemokines. ISRN Inflamm. 2013, 2013, 139239. [CrossRef] [PubMed]
106. Gamboa-Gomez, C.I.; Rocha-Guzman, N.E.; Gallegos-Infante, J.A.; Moreno-Jimenez, M.R.; Vazquez-Cabral, B.D.; Gonzalez-Laredo, R.F. Plants with potential use on obesity and its complications. EXCLI J. 2015, 14, 809–831. [PubMed]
107. Gambero, A.; Ribeiro, M.L. The positive effects of yerba maté (Ilex paraguariensis) in obesity. Nutrients 2015, 7, 730–750. [CrossRef] [PubMed]
108. Park, H.; Hwang, Y.H.; Kim, D.G.; Jeon, J.; Ma, J.Y. Hepatoprotective effect of herb formula KIOM2012h against nonalcoholic fatty liver disease. Nutrients 2015, 7, 2440–2455. [CrossRef] [PubMed]
109. Chen, Q.; Wang, T.; Li, J.; Wang, S.; Feng, Q.; Yu, H.; Zhang, Y.; Wang, T. Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD). Nutrients 2017, 9. [CrossRef] [PubMed]
110. Nishioka, A.; Nerurkar, P. Effects of Morinda citrifolia (noni) on obesity and glucose tolerance in C57Bl/6 mice. FASEB J. 2007, 21, 781.714.
111. Shoeb, A.; Alwar, M.C.; Shenoy, P.J.; Gokul, P. Effect of Morinda citrifolia (noni) fruit juice on high fat diet induced dyslipidemia in rats. J. Clin. Diagn. Res. 2016, 10, FF06–FF10. [CrossRef] [PubMed]
112. Gooda Sahib Jambocus, N.; Saari, N.; Ismail, A.; Khatib, A.; Mahomoodally, M.F.; Abdul Hamid, A. An investigation into the antiobesity effects of Morinda citrifolia L. leaf extract in high fat diet induced obese rats using a (1)HNMR metabolomics approach. J. Diabetes Res. 2016, 2016. [CrossRef] [PubMed]
113. Juhel, C.; Armand, M.; Pafumi, Y.; Rosier, C.; Vandermander, J.; Lairon, D. Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J. Nutr. Biochem. 2000, 11, 45–51. [CrossRef]
114. Moreno, D.A.; Ilic, N.; Poulev, A.; Raskin, I. Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters. Life Sci. 2006, 78, 2797–2803. [CrossRef] [PubMed]
115. Ardévol, A.; Bladé, C.; Salvadó, M.J.; Arola, L. Changes in lipolysis and hormone-sensitive lipase expression caused by procyanidins in 3T3-L1 adipocytes. Int. J. Obes. Relat. Netab. Disord. 2000, 24, 319–324. [CrossRef]
116. Rosen, E.D.; Walkey, C.J.; Puigserver, P.; Spiegelman, B.M. Transcriptional regulation of adipogenesis. Genes Dev. 2000, 14, 1293–1307. [PubMed]
117. Berger, J.; Moller, D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 2002, 53, 409–435. [CrossRef] [PubMed]
118. Aoyama, T.; Peters, J.M.; Iritani, N.; Nakajima, T.; Furihata, K.; Hashimoto, T.; Gonzalez, F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPAR-α). J. Biol. Chem. 1998, 273, 5678–5684. [CrossRef] [PubMed]
119. Muoio, D.M.; Way, J.M.; Tanner, C.J.; Winegar, D.A.; Kliewer, S.A.; Houmard, J.A.; Kraus, W.E.; Dohm, G.L. Peroxisome proliferators-activated receptor-α regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 2002, 51, 901–909. [CrossRef] [PubMed]
120. Deng, S.; West, B.J.; Palu, A.K.; Zhou, B.N.; Jensen, C.J. Noni as an anxiolytic and sedative: A mechanism involving its gamma-aminobutyric acidergic effects. Phytomedicine 2007, 14, 517–522. [CrossRef] [PubMed]
121. Li, H.; Kang, J.H.; Han, J.M.; Cho, M.H.; Chung, Y.J.; Park, K.H.; Shin, D.H.; Park, H.Y.; Choi, M.S.; Jeong, T.S. Anti-obesity effects of soy leaf via regulation of adipogenic transcription factors and fat oxidation in diet-induced obese mice and 3T3-L1 adipocytes. J. Med. Food 2015, 18, 899–908. [CrossRef] [PubMed]
122. Boucher, J.; Kleinridders, A.; Kahn, C.R. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb. Perspect. Biol. 2014, 6, 1–23. [CrossRef] [PubMed]
123. Bettaieb, A.; Matsuo, K.; Matsuo, I.; Wang, S.; Melhem, R.; Koromilas, A.E.; Haj, F.G. Protein Tyrosine Phosphatase 1b deficiency potentiates PERK/EIF2α signaling in brown adipocytes. PLoS ONE 2012, 7, e34412. [CrossRef] [PubMed]
124. Zabolotny, J.M.; Bence-Hanulec, K.K.; Stricker-Krongrad, A.; Haj, F.; Wang, Y.; Minokoshi, Y.; Kim, Y.B.; Elmquist, J.K.; Tartaglia, L.A.; Kahn, B.B.; et al. PT1b regulates leptin signal transduction in vivo. Dev. Cell 2002, 2, 489–495. [CrossRef]
125. Nguyen, P.H.; Le, T.V.; Kang, H.W.; Chae, J.; Kim, S.K.; Kwon, K.I.; Seo, D.B.; Lee, S.J.; Oh, W.K. AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. Bioorg. Med. Chem. Lett. 2010, 20, 4128–4131. [CrossRef] [PubMed]
126. Kampkotter, A.; Timpel, C.; Zurawski, R.F.; Ruhl, S.; Chovolou, Y.; Proksch, P.; Watjen,W. Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2008, 149, 314–323. [CrossRef] [PubMed]
127. Takikawa, M.; Inoue, S.; Horio, F.; Tsuda, T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J. Nutr. 2010, 140, 527–533. [CrossRef] [PubMed]
128. Viollet, B.; Foretz, M.; Guigas, B.; Horman, S.; Dentin, R.; Bertrand, L.; Hue, L.; Andreelli, F. Activation of AMP-activated protein kinase in the liver: A new strategy for the management of metabolic hepatic disorders. J. Physiol. 2006, 574, 41–53. [CrossRef] [PubMed]
129. Nolan, J.J.; Ludvik, B.; Beerdsen, P.; Joyce, M.; Olefsky, J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with trioglitazone. N. Engl. J. Med. 1994, 331, 1188–1193. [CrossRef] [PubMed]
130. Ferré, P. The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53, S43–S50. [CrossRef] [PubMed]
131. Nayak, B.S.; Isitor, G.N.; Maxwell, A.; Bhogadi, V.; Ramdath, D.D. Wound-healing activity of Morinda citrifolia fruit juice on diabetes-induced rats. J. Wound Care 2007, 16, 83–86. [CrossRef] [PubMed]
132. Nayak, B.S.; Marshall, J.R.; Isitor, G.; Adogwa, A. Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (noni) in diabetic rats. Evid. Based Complement. Alternat. Med. 2011, 2011, 875293. [CrossRef] [PubMed]
133. Scortichini, M.; Rossi, M.P. Preliminary in vitro evaluation of the antimicrobial activity of triterpenes and terpenoids towards Erwinia amylovora (burrill) winslow et al. J. Appl. Bacteriol. 1991, 71, 109–112. [CrossRef]
134. Chen, J.; Li, W.L.; Wu, J.L.; Ren, B.R.; Zhang, H.Q. Hypoglycemic effects of a sesquiterpene glycoside isolated from leaves of loquat (Eriobotrya japonica (Thunb.) Lindl.). Phytomedicine 2008, 15, 98–102. [CrossRef] [PubMed]
135. De Tommasi, N.; De Simone, F.; Cirino, G.; Cicala, C.; Pizza, C. Hypoglycemic effects of sesquiterpene glycosides and polyhydroxylated triterpenoids of Eriobotrya japonica. Planta Med. 1991, 57, 414–416. [CrossRef] [PubMed]
136. Horsfall, A.U.; Olabiyi, O.; Aiyegbusi, A.; Noronha, C.C.; Okanlawon, A.O. Morinda citrifolia fruit juice augments insulin action in sprague-dawley rats with experimentally induced diabetes. Niger. Q. J. Hosp. Med. 2008, 18, 162–165. [CrossRef]
137. Bechmann, L.P.; Hannivoort, R.A.; Gerken, G.; Hotamisligil, G.S.; Trauner, M.; Canbay, A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol. 2012, 56, 952–964. [CrossRef] [PubMed]
138. Quresh, K.; Abrams, G.A. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol. 2007, 13, 3540–3553. [CrossRef]
139. Younossi, Z.M.; Koenig, A.B.; Abdelatif, D.; Fazel, Y.; Henry, L.; Wymer, M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016, 64, 73–84. [CrossRef] [PubMed]
140. Smits, M.M.; Ioannou, G.N.; Boyko, E.J.; Utzschneider, K.M. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a U.S. national survey in three ethnic groups. J. Gastroenterol. Hepatol. 2013, 28, 664–670. [CrossRef] [PubMed]
141. Woo Baidal, J.A.; Lavine, J.E. The intersection of nonalcoholic fatty liver disease and obesity. Sci. Transl. Med. 2016, 8, 323rv321. [CrossRef] [PubMed]
142. Joshi, R.; Gangabhagirathi, R.; Venu, S.; Adhikari, S.; Mukherjee, T. Antioxidant activity and free radical scavenging reactions of gentisic acid: In Vitro and pulse radiolysis studies. Free Radic. Res. 2012, 46, 11–20. [CrossRef] [PubMed]
143. Pari, L.; Karthikesan, K.; Menon, V.P. Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes. Mol. Cell Biochem. 2010, 341, 109–117. [CrossRef] [PubMed]
144. Huang, G.J.; Liao, J.C.; Chiu, C.S.; Huang, S.S.; Lin, T.H.; Deng, J.S. Anti-inflammatory activities of aqueous extract of Mesona procumbens in experimental mice. J. Sci. Food Agric. 2012, 92, 1186–1193. [CrossRef] [PubMed]
145. Cho, A.S.; Jeon, S.M.; Kim, M.J.; Yeo, J.; Seo, K.I.; Choi, M.S.; Lee, M.K. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem. Toxicol. 2010, 48, 937–943. [CrossRef] [PubMed]
146. Huang, T.W.; Chang, C.L.; Kao, E.S.; Lin, J.H. Effect of Hibiscus sabdariffa extract on high fat diet-induced obesity and liver damage in hamsters. Food Nutr. Res. 2015, 59, 29018. [CrossRef] [PubMed]
147. Ham, J.R.; Lee, H.-I.; Choi, R.-Y.; Sim, M.-O.; Choi, M.-S.; Kwon, E.-Y.; Yun, K.W.; Kim, M.-J.; Lee, M.-K. Anti-obesity and anti-hepatosteatosis effects of dietary scopoletin in high-fat diet fed mice. J. Funct. Food 2016, 25, 433–446. [CrossRef]
148. Hurtubise, J.; McLellan, K.; Durr, K.; Onasanya, O.; Nwabuko, D.; Ndisang, J.F. The different facets of dyslipidemia and hypertension in atherosclerosis. Curr. Atheroscler. Rep. 2016, 18, 82. [CrossRef] [PubMed]
149. Atabek, M.E.; Akyurek, N.; Eklioglu, B.S.; Alp, H. Impaired systolic blood dipping and nocturnal hypertension: An independent predictor of carotid intima-media thickness in type 1 diabetic patients. J. Diabetes Complicat. 2014, 28, 51–55. [CrossRef] [PubMed]
150. Pan, W.H.; Bai, C.H.; Chen, J.R.; Chiu, H.C. Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. Stroke 1997, 28, 88–94. [CrossRef] [PubMed]
151. Reina, S.A.; Llabre, M.M.; Allison, M.A.; Wilkins, J.T.; Mendez, A.J.; Arnan, M.K.; Schneiderman, N.; Sacco, R.L.; Carnethon, M.; Delaney, J.A. HDL cholesterol and stroke risk: The multi-ethnic study of atherosclerosis. Atherosclerosis 2015, 243, 314–319. [CrossRef] [PubMed]
152. Montserrat-de la Paz, S.; Bermudez, B.; Cardelo, M.P.; Lopez, S.; Abia, R.; Muriana, F.J. Olive oil and postprandial hyperlipidemia: Implications for atherosclerosis and metabolic syndrome. Food Funct. 2016, 7, 4734–4744. [CrossRef] [PubMed]
153. Grundy, S.M.; Cleeman, J.I.; Merz, C.N.; Brewer, H.B Jr., Clark, L.T.; Hunninghake, D.B.; Pasternak, R.C.; Smith, S.C., Jr.; Stone, N.J. et al; National Heart, L. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004, 110, 227–239. [CrossRef] [PubMed]
154. Mandukhail, S.U.; Aziz, N.; Gilani, A.H. Studies on antidyslipidemic effects of Morinda citrifolia (noni) fruit, leaves and root extracts. Lipids Health Dis. 2010, 9, 88. [CrossRef] [PubMed]
155. Ojewole, J.A.O.; Adesina, S.K. Mechanism of the hypotensive effect of scopoletin isolated from the fruit of Tetrapleura tetraptera. Planta Med. 1983, 49, 46–50. [CrossRef] [PubMed]
156. Kumar, R.; Kumar, A.; Sharma, R.; Baruwa, A. Pharmacological review on natural ACE inhibitors. Der Pharm. Lett. 2010, 2, 273–293.
157. Ghayur, M.N.; Gilani, A.H. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J. Cardiovasc. Pharmacol. 2005, 45, 74–80. [CrossRef] [PubMed]
158. Schroeder, B.O.; Backhed, F. Signals from the gut microbiota to distant organs in physiology and disease. Nat. Med. 2016, 22, 1079–1089. [CrossRef] [PubMed]
159. Clemente, J.C.; Ursell, L.K.; Parfrey, L.W.; Knight, R. The impact of the gut microbiota on human health: An integrative view. Cell 2012, 148, 1258–1270. [CrossRef] [PubMed]
160. Li, D.; Wang, P.; Wang, P.; Hu, X.; Chen, F. The gut microbiota: A treasure for human health. Biotechnol. Adv. 2016, 34, 1210–1224. [CrossRef] [PubMed]
161. Wang, C.Y.; Ng, C.C.; Su, H.; Tzeng, W.S.; Shyu, Y.T. Probiotic potential of noni juice fermented with lactic acid bacteria and Bifidobacteria. Int. J. Food Sci. Nutr. 2009, 60 (Suppl 6), 98–106. [CrossRef] [PubMed]
162. Huang, H.L.; Liu, C.T.; Chou, M.C.; Ko, C.H.; Wang, C.K. Noni (Morinda citrifolia L.) fruit extracts improve colon microflora and exert anti-inflammatory activities in Caco-2 cells. J. Med. Food 2015, 18, 663–676. [CrossRef] [PubMed]
163. Kurniawan, D.; Widodo, E.; Djunaidi, I.H. The effect of noni (Morinda citrifolia) fruit meal as feed additive on intestinal microfloras and villi characteristics of hybrid duck. Bul. Peternak. 2016, 40, 34–39.
164. El Kaoutari, A.; Armougom, F.; Gordon, J.I.; Raoult, D.; Henrissat, B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 2013, 11, 497–504. [CrossRef] [PubMed]
165. Bui, A.K.; Bacic, A.; Pettolino, F. Polysaccharide composition of the fruit juice of Morinda citrifolia (noni). Phytochemistry 2006, 67, 1271–1275. [CrossRef] [PubMed]
166. Huang, H.L.; Ko, C.H.; Yan, Y.Y.; Wang, C.K. Antiadhesion and anti-inflammation effects of noni (Morinda citrifolia) fruit extracts on AGS cells during Helicobacter pylori infection. J. Agric. Food Chem. 2014, 62, 2374–2383. [CrossRef] [PubMed]
167. Howell, A.B.; Reed, J.D.; Krueger, C.G.; Winterbottom, R.; Cunningham, D.G.; Leahy, M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005, 66, 2281–2291. [CrossRef] [PubMed]
168. Ghazanfari, S.; Morabi, M.A.; Bardzardi, M.M. Intestinal morphology and microbiology of broiler chicken fed diets containing myrtle (Myrtus communis) essential oil supplementation. J. Appl. Anim. Sci. 2014, 4, 549–554.